321550 — TiumBio Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual income statement for TiumBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	56.8	9,118	4,899	6,792	12,289
Cost of Revenue
Gross Profit	—	—	—	—	5,044
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	32,753	34,076	20,939	12,136	29,554
Operating Profit	-32,696	-24,958	-16,040	-5,344	-17,265
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-32,253	-31,402	-19,038	-23,546	-18,787
Provision for Income Taxes
Net Income After Taxes	-32,253	-31,402	-19,038	-23,546	-18,787
Minority Interest
Net Income Before Extraordinary Items
Net Income	-31,637	-29,853	-17,911	-20,644	-17,360
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-31,637	-29,853	-17,911	-20,644	-17,360
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,329	-1,274	-1,217	-1,316	-598
Dividends per Share